Diagnosis Assisting System, Diagnosis Assisting Method, and Program Thereof
    1.
    发明申请
    Diagnosis Assisting System, Diagnosis Assisting Method, and Program Thereof 审中-公开
    诊断辅助系统,诊断辅助方法及程序

    公开(公告)号:US20160004932A1

    公开(公告)日:2016-01-07

    申请号:US14769868

    申请日:2014-02-24

    Abstract: When making a diagnosis by synthetically taking into account the information obtained by preparing a plurality of samples using different staining methods or the like and sequentially observing the samples, a diagnostician must remember information about the plurality of samples.The present invention includes image storage means for storing a reference image obtained by photographing a predetermined stained sample of and a comparison image obtained by photographing another stained sample of substantially identical biological tissues, partial image creation means for detecting a structure of the biological tissue from the reference image, cutting out from the comparison image a partial image that contains the structure detected, and storing into partial image storage means the partial image in association with the structure and the comparison image, image output means for outputting a result image that includes the reference image and the partial image, and the partial image storage means.

    Abstract translation: 当通过综合考虑通过使用不同染色方法等制备多个样品而获得的信息并依次观察样品进行诊断时,诊断者必须记住关于多个样品的信息。 本发明包括图像存储装置,用于存储通过拍摄预定的染色样品获得的参考图像和通过拍摄基本上相同的生物组织的另一染色样本获得的比较图像;部分图像创建装置,用于从 参考图像,从所述比较图像中切出包含检测到的结构的部分图像,并且将部分图像存储装置存储为与所述结构和所述比较图像相关联的部分图像;图像输出装置,用于输出包括所述参考的结果图像 图像和部分图像以及部分图像存储装置。

    METHOD FOR DIAGNOSING HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 (HTLV-1) ASSOCIATED DISEASES

    公开(公告)号:US20220137050A1

    公开(公告)日:2022-05-05

    申请号:US17429206

    申请日:2020-02-06

    Abstract: As a technique enabling to simply and accurately diagnose human T cell leukemia virus type 1 (HTLV-1) related disease, there is provided a diagnostic method for an HTLV-1 related disease, comprising the steps of: measuring the amount of a marker protein in a blood sample taken from a subject, wherein the marker protein is at least one selected from the proteins listed in Tables 1 and 2; and, if a measured value is a predetermined reference value or more or the predetermined reference value or less, determining that the subject suffers from the HTLV-1 related disease or determining that the subject is in remission of the HTLV-1 related disease.

    METHOD AND SYSTEM OF TARGETING EPITOPES FOR NEOANTIGEN-BASED IMMUNOTHERAPY

    公开(公告)号:US20210391031A1

    公开(公告)日:2021-12-16

    申请号:US17281707

    申请日:2019-11-20

    Abstract: A method of ranking epitopes derived from neoantigens as targets for personalized immunotherapy includes collecting candidate epitopes based on patient data of a cancer patient. A set of scores are calculated for each of the candidate epitopes, each of the scores in a respective one of the sets for a respective one of the candidate epitopes representing an independent measure of a likelihood of the respective one of candidate epitopes to elicit an immune response in the cancer patient. The scores in each of the sets of scores are combined into a single score for each of the candidate epitopes. The single scores for the candidate epitopes in each case reflect an overall likelihood of eliciting the immune response in the patient. The candidate epitopes are ranked using the single scores for the immunotherapy.

Patent Agency Ranking